Athanasios Papakyriakou相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides

BRF110 是一种口服活性 Nurr1-RXRα 选择性雷西诺类药物，可在不升高甘油三酯的情况下增强 BDNF 表达。

期刊:Journal of Medicinal Chemistry

影响因子:6.8

doi:10.1021/acs.jmedchem.4c03046

Xenophon Asvos,Mohamed A El Mubarak,Theodoros Karampelas,Theodoros Rampias,Constantin Tamvakopoulos,Gregory B Sivolapenko,Athanasios Papakyriakou,Stavros Topouzis,Demetrios K Vassilatis,Demosthenes Fokas

发表日期：2025

文献求助收藏

Polymorphic positions 349 and 725 of the autoimmunity-protective allotype 10 of ER aminopeptidase 1 are key in determining its unique enzymatic properties

ER 氨基肽酶 1 的自身免疫保护同种型 10 的多态性位置 349 和 725 是决定其独特酶特性的关键

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2024.1415964

Galateia Georgaki, Anastasia Mpakali, Myrto Trakada, Athanasios Papakyriakou, Efstratios Stratikos

发表日期：2024

文献求助收藏

Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors

基于结构发现核因子 κB 受体激活剂配体 (RANKL) 诱导的破骨细胞生成抑制剂

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms241411290

Vagelis Rinotas, Fotini Liepouri, Maria-Dimitra Ouzouni, Niki Chalkidi, Christos Papaneophytou, Mariza Lampropoulou, Veroniki P Vidali, George Kontopidis, Elias Couladouros, Elias Eliopoulos, Athanasios Papakyriakou, Eleni Douni

细胞生物学

发表日期：2023

文献求助收藏

The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor

新型选择性 LMTK3 激酶抑制剂的抑制特性

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms24010865

Alessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou, Viviana Vella, Mark Samuels, Panagiotis Papanastasopoulos, Christina Giamas, Erika J Mancini, Justin Stebbing, John Spencer, Chiara Cilibrasi, Angeliki Ditsiou, Georgios Giamas

发表日期：2023

文献求助收藏

Design, synthesis and biological evaluation of new 3,4-dihydroquinoxalin-2(1 H)-one derivatives as soluble guanylyl cyclase (sGC) activators

新型 3,4-二氢喹喔啉-2(1H)-酮衍生物作为可溶性鸟苷酸环化酶 (sGC) 激活剂的设计、合成及生物学评价

影响因子:3.4

doi:10.1016/j.heliyon.2022.e11438

Dionysios-Panagiotis Kintos, Konstantinos Salagiannis, Vasiliki Vazoura, Theresa Wittrien, Athanasios Papakyriakou, Sotiris S Nikolaropoulos, Soenke Behrends, Stavros Topouzis, Manolis A Fousteris

发表日期：2022

文献求助收藏

5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action

5-ALA 是一种有效的乳酸脱氢酶抑制剂，但不是底物：对细胞糖酵解的影响以及 5-ALA 介导的抗癌作用的新途径

doi:10.3390/cancers14164003

Mantas Grigalavicius, Somayeh Ezzatpanah, Athanasios Papakyriakou, Tine Therese Henriksen Raabe, Konstantina Yannakopoulou, Theodossis A Theodossiou

发表日期：2022

文献求助收藏

The structure-function relationship of oncogenic LMTK3

致癌基因 LMTK3 的结构与功能关系

期刊:Science Advances

影响因子:11.7

doi:10.1126/sciadv.abc3099

Angeliki Ditsiou, Chiara Cilibrasi, Nikiana Simigdala, Athanasios Papakyriakou, Leanne Milton-Harris, Viviana Vella, Joanne E Nettleship, Jae Ho Lo, Shivani Soni, Goar Smbatyan, Panagiota Ntavelou, Teresa Gagliano, Maria Chiara Iachini, Sahir Khurshid, Thomas Simon, Lihong Zhou, Storm Hassell-Hart,

发表日期：2020

文献求助收藏

Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-κB Ligand with a Superior Therapeutic Index

发现具有优异治疗指数的核因子-κB受体激活剂配体小分子抑制剂

期刊:Journal of Medicinal Chemistry

影响因子:6.8

doi:10.1021/acs.jmedchem.0c01316

Vagelis Rinotas, Athanasios Papakyriakou, Foteini Violitzi, Christos Papaneophytou, Maria-Dimitra Ouzouni, Polyxeni Alexiou, Alexandros Strongilos, Elias Couladouros, George Kontopidis, Elias Eliopoulos, Eleni Douni

发表日期：2020

文献求助收藏

A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1

系统地重新检查内质网氨基肽酶 1 对 MHCI 结合抗原肽前体的加工

期刊:Journal of Biological Chemistry

doi:10.1074/jbc.RA120.012976

George Mavridis, Richa Arya, Alexander Domnick, Jerome Zoidakis, Manousos Makridakis, Antonia Vlahou, Anastasia Mpakali, Angelos Lelis, Dimitris Georgiadis, Robert Tampé, Athanasios Papakyriakou, Lawrence J Stern, Efstratios Stratikos

发表日期：2020

文献求助收藏

Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)

使用内质网氨基肽酶 1 (ERAP1) 的强效抑制剂编辑黑色素瘤细胞的免疫肽组

期刊:Cancer Immunology Immunotherapy

影响因子:8.1

doi:10.1007/s00262-019-02358-0

Despoina Koumantou, Eilon Barnea, Adrian Martin-Esteban, Zachary Maben, Athanasios Papakyriakou, Anastasia Mpakali, Paraskevi Kokkala, Harris Pratsinis, Dimitris Georgiadis, Lawrence J Stern, Arie Admon, Efstratios Stratikos

发表日期：2019

文献求助收藏